Copyright Reports & Markets. All rights reserved.

Global Neurologic Disorders Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Central Nervous System (CNS)
      • 1.4.3 Peripheral Nervous System (PNS)
    • 1.5 Market by Application
      • 1.5.1 Global Neurologic Disorders Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Paralysis
      • 1.5.3 Muscle Weakness
      • 1.5.4 Poor Coordination
      • 1.5.5 Loss of Sensation
      • 1.5.6 Seizures
      • 1.5.7 Confusion
      • 1.5.8 Pain and Altered Levels of Consciousness
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Neurologic Disorders Therapeutics Market Size
    • 2.2 Neurologic Disorders Therapeutics Growth Trends by Regions
      • 2.2.1 Neurologic Disorders Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Neurologic Disorders Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Neurologic Disorders Therapeutics Market Size by by Players
      • 3.1.1 Global Neurologic Disorders Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Neurologic Disorders Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Neurologic Disorders Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Neurologic Disorders Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Neurologic Disorders Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Neurologic Disorders Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 5.2 Neurologic Disorders Therapeutics Key Players in North America
    • 5.3 North America Neurologic Disorders Therapeutics Market Size by Type
    • 5.4 North America Neurologic Disorders Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 6.2 Neurologic Disorders Therapeutics Key Players in Europe
    • 6.3 Europe Neurologic Disorders Therapeutics Market Size by Type
    • 6.4 Europe Neurologic Disorders Therapeutics Market Size by Application

    7 China

    • 7.1 China Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 7.2 Neurologic Disorders Therapeutics Key Players in China
    • 7.3 China Neurologic Disorders Therapeutics Market Size by Type
    • 7.4 China Neurologic Disorders Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 8.2 Neurologic Disorders Therapeutics Key Players in Japan
    • 8.3 Japan Neurologic Disorders Therapeutics Market Size by Type
    • 8.4 Japan Neurologic Disorders Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 9.2 Neurologic Disorders Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Neurologic Disorders Therapeutics Market Size by Type
    • 9.4 Southeast Asia Neurologic Disorders Therapeutics Market Size by Application

    10 India

    • 10.1 India Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 10.2 Neurologic Disorders Therapeutics Key Players in India
    • 10.3 India Neurologic Disorders Therapeutics Market Size by Type
    • 10.4 India Neurologic Disorders Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Neurologic Disorders Therapeutics Market Size (2014-2019)
    • 11.2 Neurologic Disorders Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Neurologic Disorders Therapeutics Market Size by Type
    • 11.4 Central & South America Neurologic Disorders Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Biogen Inc.
      • 12.1.1 Biogen Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Neurologic Disorders Therapeutics Introduction
      • 12.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2014-2019))
      • 12.1.5 Biogen Inc. Recent Development
    • 12.2 F. Hoffmann-La Roche Ltd.
      • 12.2.1 F. Hoffmann-La Roche Ltd. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Neurologic Disorders Therapeutics Introduction
      • 12.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
      • 12.2.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 12.3 Johnson & Johnson Services Inc.
      • 12.3.1 Johnson & Johnson Services Inc. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Neurologic Disorders Therapeutics Introduction
      • 12.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
      • 12.3.5 Johnson & Johnson Services Inc. Recent Development
    • 12.4 Novartis AG
      • 12.4.1 Novartis AG Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Neurologic Disorders Therapeutics Introduction
      • 12.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
      • 12.4.5 Novartis AG Recent Development
    • 12.5 Pfizer Inc.
      • 12.5.1 Pfizer Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Neurologic Disorders Therapeutics Introduction
      • 12.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2014-2019)
      • 12.5.5 Pfizer Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
      The early diagnosis of neurodegenerative indications is difficult because of their complex nature, fast progression, and lack of effective diagnostic processes. This has encouraged researchers to focus on the development of novel biomarkers that can accurately detect neurodegenerative indications.
      In 2018, the global Neurologic Disorders Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Neurologic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neurologic Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Biogen Inc.
      F. Hoffmann-La Roche Ltd.
      Johnson & Johnson Services Inc.
      Novartis AG
      Pfizer Inc.
      ...

      Market segment by Type, the product can be split into
      Central Nervous System (CNS)
      Peripheral Nervous System (PNS)

      Market segment by Application, split into
      Paralysis
      Muscle Weakness
      Poor Coordination
      Loss of Sensation
      Seizures
      Confusion
      Pain and Altered Levels of Consciousness

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Neurologic Disorders Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Neurologic Disorders Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Neurologic Disorders Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now